Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 1,618 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Lesions Clear all

Conditions: Solid Cancer, Metastatic Spinal Lesions
Interventions: Dynamic contrast enhancement MRI; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Pancreatic Cystic Lesions
Interventions: Not listed
Lead sponsor: Amplified Sciences Inc; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Indianapolis, Indiana • Boston, Massachusetts • New Brunswick, New Jersey

Conditions: Cirrhosis
Interventions: Contrast-Enhanced Ultrasound, Sulfur Hexafluoride Lipid Microspheres, Ultrasound; Procedure · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Vascular Anomaly
Interventions: Topical Sirolimus; Drug
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 36 Months to 21 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 2
States / cities: Jacksonville, Florida • Orlando, Florida

Conditions: Anal Cancer, High-grade Squamous Intraepithelial Lesion, HIV Infection, Human Papilloma Virus Infection
Interventions: imiquimod, fluorouracil, infrared photocoagulation therapy, thermal ablation therapy, laser therapy, clinical observation, laboratory biomarker analysis; Drug · Device · Other
Lead sponsor: AIDS Malignancy Consortium; Network
Eligibility: 35 Years and older
Enrollment: 4,446 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 24
States / cities: Los Angeles, California • Palm Springs, California • San Francisco, California + 13 more

Conditions: Epidermolysis Bullosa
Interventions: Cellutome Epidermal Harvesting System; Device
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: Not listed
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Choroidal Melanoma, Indeterminate Lesions of Eye
Interventions: Not listed
Lead sponsor: Aura Biosciences; Industry
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2029
U.S. locations: 16
States / cities: Tucson, Arizona • Los Angeles, California • Palo Alto, California + 13 more

Conditions: In-Stent Restenosis, Cardiovascular Diseases, Coronary Artery Disease
Interventions: Sirolimus Drug Coated Balloon, Plan balloon Angioplasty (POBA); Device
Lead sponsor: Concept Medical Inc.; Industry
Eligibility: 18 Years to 110 Years
Enrollment: 492 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 27
States / cities: Birmingham, Alabama • Gilbert, Arizona • Los Angeles, California + 21 more

Conditions: GI Lesions
Interventions: Pro Core Needle, medtronic Sharkcore Needle; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Inoperable Solid Tumors or Lymphomas
Interventions: AvidinOX, 177Lu-ST2210; Drug
Lead sponsor: Alfasigma S.p.A.; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Lung Nodule, Lung Mass, Lesion of the Lung
Interventions: Cone Beam CT with Embo Guide to creat 3D Overlay and CT Augmented Fluoroscopy to guide Electromagnetic Navigational Bronchoscopy instead of Standard Fluroscopic guidance using the C-Arm; Procedure
Lead sponsor: Columbus Regional Health; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Columbus, Indiana

Conditions: Cardiovascular Disease
Interventions: EVARREST™ Fibrin Sealant Patch, Topical hemostat; Biological
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 9
States / cities: Atlanta, Georgia • Indianapolis, Indiana • Baltimore, Maryland + 6 more

Conditions: Peripheral Pulmonary Lesions
Interventions: ILLUMISITE™ Platform (EMN bronchoscopy), Ion™ Endoluminal System (SSCB bronchoscopy); Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 447 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Tooth Demineralization
Interventions: MI Paste Plus, PreviDent Fluoride Varnish, Normal Home Care; Procedure
Lead sponsor: University of Washington; Other
Eligibility: 12 Years to 20 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Solid Pancreatic Mass Lesions
Interventions: Suction; Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Relapsing Multiple Sclerosis
Interventions: Remibrutinib, Teriflunomide; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 1,007 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2030
U.S. locations: 50
States / cities: Phoenix, Arizona • Hanford, California • Los Angeles, California + 42 more

Conditions: Cardiovascular Disease
Interventions: EVARREST™, Topical hemostat, Standard of Care; Biological · Other
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 6
States / cities: Indianapolis, Indiana • Kansas City, Missouri • Camden, New Jersey + 2 more

Conditions: Dental Caries
Interventions: Fluoride; Drug
Lead sponsor: Indiana Nanotech, LLC; Other
Eligibility: 13 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Tattoo; Pigmentation, Melasma, Benign Pigmented Lesion
Interventions: PicoPlus laser system; Device
Lead sponsor: CynosureLutronic; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 4
States / cities: Newport Beach, California • Elmhurst, New York • New York, New York + 1 more

Conditions: Opioid Use, Pain, Post Operative
Interventions: nCAP Signal Relief Patch, Standard of Care; Device · Other
Lead sponsor: Jacques E. Chelly; Other
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Enamel Caries
Interventions: Experimental Toothpaste containing 1450ppm SMFP, Toothpaste containing 1450ppm SMFP, Toothpaste with no fluoride; Other
Lead sponsor: Unilever R&D; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Peripheral Artery Disease
Interventions: Tack Endovascular System; Device
Lead sponsor: Philips Clinical & Medical Affairs Global; Industry
Eligibility: 18 Years and older
Enrollment: 213 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 36
States / cities: Yuma, Arizona • Little Rock, Arkansas • Beverly Hills, California + 31 more

Conditions: Infection, Precancerous Condition
Interventions: Gardasil; Biological
Lead sponsor: AIDS Malignancy Consortium; Network
Eligibility: 18 Years and older · Male only
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 8
States / cities: Los Angeles, California • San Francisco, California • Denver, Colorado + 4 more

Conditions: Intraoperative Bleeding, Hemorrhage, Surgical, Liver Diseases
Interventions: GATT-Patch (currently named ETHIZIA), TachoSil; Device · Drug
Lead sponsor: GATT Technologies BV; Industry
Eligibility: 22 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 6
States / cities: Los Angeles, California • St Louis, Missouri • Newark, New Jersey + 3 more

Search by objective public record fields.

Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion

A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions

Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis

Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions

Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions

Study of Cellutome System for Treatment of Individual Lesions in EB Pts

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Endoscopic Ultrasound (EUS) Fine Needle Biopsy (FNB) Submucosal Nodule

Safety, Tolerability, PK, Dosimetry, MTD and Preliminary Efficacy of Intra-lesionally Injected AvidinOX, Followed by IV Escalating Doses of [177Lu]DOTA-biotin in Pts With Injectable Solid Tumors or Lymphomas

Cone Beam CT Guided Electromagnetic Navigational Bronchoscopy

The Fibrin Pad CV Phase III Study

Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)

Study of Treatments Used for White Spot Lesions After Orthodontic Treatment.

EUS-FNA With and Without Suction

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)

The Fibrin Pad Cardiovascular Study

Development and Validation of a Multi-Mineral Fluoride Mouthrinse

Lutronic PicoPlus Exploratory Clinical Trial

A Pilot Study Investigating the nCAP Signal Relief Patch in Subjects Undergoing Primary Hip or Knee Replacement Surgery

Evaluation of Efficacy of Sodium Monofluorophosphate (SMPF) Toothpastes on Enamel Lesion Remineralisation

Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

GATT-Patch Versus TachoSil in Liver Surgery